Tumor vessel co-option: The past & the future

Tumor vessel co-option (VCO) is a non-angiogenic vascularization mechanism that is a possible cause of resistance to anti-angiogenic therapy (AAT). Multiple tumors are hypothesized to primarily rely on growth factor signaling-induced sprouting angiogenesis, which is often inhibited during AAT. Durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuypers, Anne, Truong, Anh-Co Khanh, Becker, Lisa M., Saavedra-García, Paula, Carmeliet, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472251/
https://www.ncbi.nlm.nih.gov/pubmed/36119528
http://dx.doi.org/10.3389/fonc.2022.965277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472251/
https://www.ncbi.nlm.nih.gov/pubmed/36119528
http://dx.doi.org/10.3389/fonc.2022.965277

Ejemplares similares